Drug Therapies for the Treatment of Multiple Sclerosis

被引：3

作者：

Ryan, Melody ^{[1
,2
]}

机构：

[1] Univ Kentucky, Coll Pharm, Dept Pharm Practice & Sci, Lexington, KY USA

[2] Univ Kentucky, Coll Med, Dept Neurol, Lexington, KY USA

来源：

JOURNAL OF INFUSION NURSING | 2009年 / 32卷 / 03期

关键词：

D O I：

10.1097/NAN.0b013e3181a1a895

中图分类号：

R47 [护理学];

学科分类号：

1011 [护理学];

摘要：

The name multiple sclerosis (MS) refers to 2 features of the disease: multiple describes the number of central nervous system lesions and sclerosis refers to the demyelinated nature of the lesions. Today, these lesions are usually called plaques rather than scleroses. Multiple sclerosis is a complex inflammatory disease of the central nervous system that is variable in terms of symptoms and presentation. The objectives of this article are to review briefly the epidemiology and pathophysiology of MS and to focus on the major categories of therapies currently in use to treat MS. Research is progressing at a rapid pace. The article also discusses some of the most promising new compounds in clinical trials.

引用

页码：137 / 144

页数：8

共 56 条

[1]

METHYLPREDNISOLONE IN MULTIPLE-SCLEROSIS - A COMPARISON OF ORAL WITH INTRAVENOUS THERAPY AT EQUIVALENT HIGH-DOSE [J].

ALAM, SM ;

KYRIAKIDES, T ;

LAWDEN, M ;

NEWMAN, PK .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1993, 56 (11) :1219-1220

[2]

Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial [J].

Bar-Or, Amit ;

Calabresi, Peter A. J. ;

Arnlod, Douglas ;

Markowitz, Clyde ;

Shafer, Stuart ;

Kasper, Lloyd H. ;

Waubant, Ernmanuelle ;

Gazda, Suzanne ;

Fox, Robert J. ;

Panzara, Michael ;

Sarkar, Neena ;

Agarwal, Sunil ;

Smith, Craig H. .

ANNALS OF NEUROLOGY, 2008, 63 (03) :395-400

[3]

Evaluation of software-based telephone Counseling to enhance medication persistency among patients with multiple sclerosis [J].

Berger, Bruce A. ;

Liang, Huigang ;

Hudmon, Karen Suchanek .

JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2005, 45 (04) :466-472

[4]

Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis [J].

Birnbaum, G. ;

Cree, B. ;

Altafullah, I. ;

Zinser, M. ;

Reder, A. T. .

NEUROLOGY, 2008, 71 (18) :1390-1395

[5]

Effects of glatiramer acetate on relapse rate and accumulated disability in multiple sclerosis: meta-analysis of three double-blind, randomized, placebo-controlled clinical trials [J].

Boneschi, FM ;

Rovaris, M ;

Johnson, KP ;

Miller, A ;

Wolinsky, JS ;

Ladkani, D ;

Shifroni, G ;

Comi, G ;

Filippi, M .

MULTIPLE SCLEROSIS, 2003, 9 (04) :349-355

[6]

The incidence and significance of anti-natalizumab antibodies -: Results from AFFIRM and SENTINEL [J].

Calabresi, P. A. ;

Giovannoni, G. ;

Confavreux, C. ;

Galetta, S. L. ;

Havrdova, E. ;

Hutchinson, M. ;

Kappos, L. ;

Miller, D. H. ;

O'Connor, P. W. ;

Phillips, J. T. ;

Polman, C. H. ;

Radue, E. -W. ;

Rudick, R. A. ;

Stuart, W. H. ;

Lublin, F. D. ;

Wajgt, A. ;

Weinstock-Guttman, B. ;

Wynn, D. R. ;

Lynn, F. ;

Panzara, M. A. ;

Macdonell, R. ;

Hughes, A. ;

Taylor, I. ;

Lee, Y. C. ;

Ma, H. ;

King, J. ;

Kilpatrick, T. ;

Butzkueven, H. ;

Marriott, M. ;

Pollard, J. ;

Spring, P. ;

Spies, J. ;

Barnett, M. ;

Dehaene, I. ;

Vanopdenbosch, L. ;

D'Hooghe, M. ;

Van Zandijcke, M. ;

Derijck, O. ;

Seeldrayers, P. ;

Jacquy, J. ;

Piette, T. ;

De Cock, C. ;

Medaer, R. ;

Soors, P. ;

Vanroose, E. ;

Vanderhoven, L. ;

Nagels, G. ;

Dubois, B. ;

Deville, M. -C. ;

D'Haene, R. .

NEUROLOGY, 2007, 69 (14) :1391-1403

[7]

Mechanisms of action for treatments in multiple sclerosis - Does a heterogeneous disease demand a multi-targeted therapeutic approach? [J].

Chofflon, M .

BIODRUGS, 2005, 19 (05) :299-308

[8]

Mitoxantrone treatment of multiple sclerosis - Safety considerations [J].

Cohen, BA ;

Mikol, DD .

NEUROLOGY, 2004, 63 (12) :S28-S32

[9]

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study [J].

Comi, G. ;

Pulizzi, A. ;

Rovaris, M. ;

Abramsky, O. ;

Arbizu, T. ;

Boiko, A. ;

Gold, R. ;

Havrdova, E. ;

Komoly, S. ;

Selmaj, K. W. ;

Sharrack, B. ;

Filippi, M. .

LANCET, 2008, 371 (9630) :2085-2092

[10]

Effect of early interferon treatment on conversion to definite multiple sclerosis:: a randomised study [J].

Comi, G ;

Filippi, M ;

Barkhof, F ;

Durelli, L ;

Edan, G ;

Fernández, O ;

Hartung, HP ;

Seeldrayers, P ;

Sorensen, PS ;

Rovaris, M ;

Martinelli, V ;

Hommes, OR .

LANCET, 2001, 357 (9268) :1576-1582

← 1 2 3 4 5 6 →